Cargando…
Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
Autores principales: | Metzger, Philipp, Kirchleitner, Sabrina V., Kluge, Michael, Koenig, Lars M., Hörth, Christine, Rambuscheck, Carlotta A., Böhmer, Daniel, Ahlfeld, Julia, Kobold, Sebastian, Friedel, Caroline C., Endres, Stefan, Schnurr, Max, Duewell, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916026/ https://www.ncbi.nlm.nih.gov/pubmed/31843014 http://dx.doi.org/10.1186/s40425-019-0830-7 |
Ejemplares similares
-
Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019) -
Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies
por: Metzger, Philipp, et al.
Publicado: (2018) -
Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma
por: Duewell, Peter, et al.
Publicado: (2015) -
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model
por: Metzger, Philipp, et al.
Publicado: (2020) -
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
por: Ruzicka, Michael, et al.
Publicado: (2019)